Patents by Inventor Alexander Buesser

Alexander Buesser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230092186
    Abstract: A method for generating a software-implemented module for determining a glucose value in a body fluid. A first set of input data indicative of first values measured for first and a second input parameters is provided. A second set of input data indicative of second values for the first and second input parameters is also provided. The first and second sets of input data are processed by a physiological model to determine first and second sets of glucose values, respectively, in a body fluid. Training data is determined and a set of test data different from the training data is also determined. A software-implemented machine learning model configured to determine a glucose value in a body fluid of a patient is provided and is trained by the training data and is tested by the test data.
    Type: Application
    Filed: November 18, 2022
    Publication date: March 23, 2023
    Inventors: Larissa Becka, Alexander Buesser, Tony Huschto, Yannick Klopfenstein, David Mesterhazy, Mike Rinderknecht, Christian Ringemann
  • Publication number: 20210118570
    Abstract: The disclosure relates to a method for screening a subject for the risk of chronic kidney disease (CKD), comprising: receiving marker data indicative for a plurality of marker parameters for a subject, such plurality of marker parameters indicating, for the subject for a measurement period, an age value, a sample level of creatinine, and a sample level of albumin; and determining a risk factor indicative of the risk of suffering CKD for the subject from the plurality of marker parameters, wherein the determining comprises: weighting the age value higher than the sample level of albumin, and weighting the sample level of creatinine higher than the sample level of albumin. Further, a computer-implemented method for screening a subject and a method for screening a subject for the risk of chronic kidney disease (CKD) are provided.
    Type: Application
    Filed: March 22, 2019
    Publication date: April 22, 2021
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Wolfgang Petrich, Tony Huschto, Bernd Schneidinger, Stefan Ravizza, Alexander Buesser